Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade-Reference-Cited by-同舟云学术

Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade

Published:2020-04 Issue:2 Volume:30 Page:147-158
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Anderson Katie L.,Snyder Kristin M.,Ito Daisuke,Lins Debra C.,Mills Lauren J.,Weiskopf Kipp,Ring Nan G.,Ring Aaron M.,Shimizu Yoji,Mescher Matthew F.,Weissman Irving L.,Modiano Jaime F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference32 articles.

1. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.;Goswami;Cell Immunol,2017

2. Programmed cell removal: a new obstacle in the road to developing cancer.;Chao;Nat Rev Cancer,2011

3. Calreticulin exposure dictates the immunogenicity of cancer cell death.;Obeid;Nat Med,2007

4. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.;Majeti;Cell,2009

5. The CD47-signal regulatory protein alpha (sirpa) interaction is a therapeutic target for human solid tumors.;Willingham;Proc Natl Acad Sci U S A,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulating macrophage-mediated programmed cell removal: An attractive strategy for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. An “All‐In‐One” Immunomodulator‐Engineered Clinical Translatable Immunotherapy of Advanced Hepatocellular Carcinoma;Advanced Healthcare Materials;2024-04-03

3. Targeting HDAC6 improves anti-CD47 immunotherapy;Journal of Experimental & Clinical Cancer Research;2024-02-27

4. Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy;Oncology Research;2024

5. Human CD47-Derived Cyclic Peptides Enhance Engulfment of mAb-Targeted Melanoma by Primary Macrophages;Bioconjugate Chemistry;2022-03-14